Sowell Financial Services’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,558	Closed	-$231K	–	1123
2025 Q3	$231K	Buy	+3,558	New	+$204K	0.01%	935
2025 Q2	–	Sell	-11,554	Closed	-$393K	–	1050
2025 Q1	$393K	Buy	11,554 +900	+8%	+$38.2K	0.02%	659
2024 Q4	$419K	Buy	+10,654	New	+$503K	0.02%	428
2021 Q2	–	Sell	-715	Closed	-$77K	–	976
2021 Q1	$77K	Buy	715 +162	+29%	+$24.5K	﹤0.01%	1484
2020 Q4	$85K	Buy	553 +61	+12%	+$7.21K	﹤0.01%	1212
2020 Q3	$41K	Buy	492 +120	+32%	+$10.6K	﹤0.01%	1283
2020 Q2	$27K	Buy	372 +67	+22%	+$3.92K	﹤0.01%	1359
2020 Q1	$13K	Buy	305 +195	+177%	+$10.1K	﹤0.01%	1520
2019 Q4	$7K	Buy	110 +60	+120%	+$3.28K	﹤0.01%	1795
2019 Q3	$2K	Buy	+50	New	+$2.39K	﹤0.01%	2049